Abbott's Medical Devices segment, especially CGM, continues to deliver robust double-digit growth, offsetting Nutrition ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Looking ahead, Abbott forecast organic sales growth in the range of 6.5% to 7.5%, the midpoint of which missed Wall Street ...

Abbott reports fourth-quarter sales that miss analysts’ estimates.

The medical-products maker’s shares tumbled after its quarterly profit and sales underwhelmed investors.

Parents, double-check that baby formula in the pantry. After an outbreak of botulism that hospitalized dozens of babies last winter, the FDA has discovered a potential source. After 51 babies fell ill ...

LONDON, Jan 23 (Reuters) - French food and beverage maker Danone said on Friday it was recalling specific baby formula ...

Foodwatch International is preparing legal action against Nestlé, Lactalis and authorities as recalls linked to ...

By Alexander Marrow, Mateusz Rabiega and Sybille de La Hamaide Jan 21 (Reuters) - Three of the world's largest dairy ...

In statements late Friday afternoon, both the Food and Drug Administration and the Centers for Disease Control and Prevention ...

Danone and Lactalis block and recall formula batches amid cereulide concerns linked to ARA oil, following Nestlé’s global recall and rising safety scrutiny.